LTS Executive Board

The team of the Executive Board shapes the future of LTS as market leader for transdermal innovative solutions. Some of the most important tasks of the LTS Executive Board are the development of corporate strategy, the fixing of the company budged as well as the allocation of resources. It informs the Supervisory Board on a regular basis in a timely and comprehensive manner about all questions relevant to LTS AG, e.g., planning, corporate development, risk analyses and risk management.

Sebastiaan M. van Buijtenen

Chairman of the Executive Board

More than 20 years of experience in Pharma and Human Nutrition in different global and regional leadership positions;
Joined LTS in 2020, as Chairman of the Executive Board

H. Werner Lüscher
H. Werner LüscherChief Financial Officer, Executive Board Member
More than 20 years of experience in industry and consultancy in a variety of management positions;
Joined LTS in 2000, Member of the Executive Board LTS AG since 2008
B. Michael Hoffmann
B. Michael Hoffmann Chief TechOps Officer, Executive Board Member
Joined LTS at its very start in 1984.
More than 25 years of experience in different leading positions;
Member of the Executive Board since 2016
Dr. Tim Schlange
Dr. Tim SchlangeChief Market Officer, Executive Board Member
More than 20 years experience in Life Sciences and Specialty Chemicals in different businesses and management positions;
Joined LTS in 2013, as a Member of the Executive Board
Ulrich Sielaff
Ulrich SielaffChief Legal & HR Officer, Executive Board Member
Joined LTS in 2002 and several years of experience in different leading positions;
Member of the Executive Board since 2017